MMP-2 and its implications on cardiac function and structure: Interplay with inflammation in hypertension

• Published in: Biochemical pharmacology 2023-09, Vol.215, p.115684-115684, Article 115684
• Main Authors: Ribeiro Vitorino, Thaís, Ferraz do Prado, Alejandro, Bruno de Assis Cau, Stefany, Rizzi, Elen
• Format: Article
• Language: English
• Subjects: Cardiac remodeling; Hypertension; Inflammation; MMP-2
• ISSN: 0006-2952; 1873-2968
• DOI: 10.1016/j.bcp.2023.115684

[Display omitted] Hypertension is one of the leading risk factors for the development of heart failure. Despite being a multifactorial disease, in recent years, preclinical and clinical studies suggest strong evidence of the pivotal role of inflammatory cells and cytokines in the remodeling process and cardiac dysfunction. During the heart remodeling, activation of extracellular matrix metalloproteinases (MMPs) occurs, with MMP-2 being one of the main proteases secreted by cardiomyocytes, fibroblasts, endothelial and inflammatory cells in cardiac tissue. In this review, we will address the process of cardiac remodeling and injury induced by the increase in MMP-2 and the main signaling pathways involving cytokines and inflammatory cells in the process of transcriptional, secretion and activation of MMP-2. In addition, an interaction and coordinated action between MMP-2 and inflammation are explored and significant in maintaining the cardiac cycle. These observations suggest that new therapeutic opportunities targeting MMP-2 could be used to reduce inflammatory biomarkers and reduce cardiac damage in hypertension.